485 related articles for article (PubMed ID: 34836751)
21. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
Kumar R; Rathi H; Haq A; Wimalawansa SJ; Sharma A
Virus Res; 2021 Jan; 292():198235. PubMed ID: 33232783
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibody therapy in COVID-19.
Conti P; Pregliasco FE; Calvisi V; Caraffa Al; Gallenga CE; Kritas SK; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(2):423-427. PubMed ID: 33904269
[TBL] [Abstract][Full Text] [Related]
23. COVID-19 Induces Cytokine Storm and Dysfunctional Hemostasis.
Charles J; Ploplis VA
Curr Drug Targets; 2022; 23(17):1603-1610. PubMed ID: 36284376
[TBL] [Abstract][Full Text] [Related]
24. Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship.
D'Ardes D; Boccatonda A; Cocco G; Fabiani S; Rossi I; Bucci M; Guagnano MT; Schiavone C; Cipollone F
World J Gastroenterol; 2022 Mar; 28(11):1102-1112. PubMed ID: 35431501
[TBL] [Abstract][Full Text] [Related]
25. Role of Oxidative Stress on SARS-CoV (SARS) and SARS-CoV-2 (COVID-19) Infection: A Review.
Suhail S; Zajac J; Fossum C; Lowater H; McCracken C; Severson N; Laatsch B; Narkiewicz-Jodko A; Johnson B; Liebau J; Bhattacharyya S; Hati S
Protein J; 2020 Dec; 39(6):644-656. PubMed ID: 33106987
[TBL] [Abstract][Full Text] [Related]
26. The interplay between hypovitaminosis D and the immune dysfunction in the arteriovenous thrombotic complications of the sever coronavirus disease 2019 (COVID-19) infection.
AlNafea HM; Korish AA
Blood Coagul Fibrinolysis; 2023 Apr; 34(3):129-137. PubMed ID: 36966750
[TBL] [Abstract][Full Text] [Related]
27. Oxidative stress-induced endothelial dysfunction and decreased vascular nitric oxide in COVID-19 patients.
Montiel V; Lobysheva I; Gérard L; Vermeersch M; Perez-Morga D; Castelein T; Mesland JB; Hantson P; Collienne C; Gruson D; van Dievoet MA; Persu A; Beauloye C; Dechamps M; Belkhir L; Robert A; Derive M; Laterre PF; Danser AHJ; Wittebole X; Balligand JL
EBioMedicine; 2022 Mar; 77():103893. PubMed ID: 35219085
[TBL] [Abstract][Full Text] [Related]
28. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19.
Bernard I; Limonta D; Mahal LK; Hobman TC
Viruses; 2020 Dec; 13(1):. PubMed ID: 33375371
[TBL] [Abstract][Full Text] [Related]
29. COVID-19: imbalanced cell-mediated immune response drives to immunopathology.
Wang J; Li Q; Qiu Y; Lu H
Emerg Microbes Infect; 2022 Dec; 11(1):2393-2404. PubMed ID: 36069182
[TBL] [Abstract][Full Text] [Related]
30. IL-1 induces throboxane-A2 (TxA2) in COVID-19 causing inflammation and micro-thrombi: inhibitory effect of the IL-1 receptor antagonist (IL-1Ra).
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G; Toniato E
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1623-1627. PubMed ID: 32744052
[TBL] [Abstract][Full Text] [Related]
31. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
32. Clotting disorder in severe acute respiratory syndrome coronavirus 2.
Pujhari S; Paul S; Ahluwalia J; Rasgon JL
Rev Med Virol; 2021 May; 31(3):e2177. PubMed ID: 33022790
[TBL] [Abstract][Full Text] [Related]
33. Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies.
Xu SW; Ilyas I; Weng JP
Acta Pharmacol Sin; 2023 Apr; 44(4):695-709. PubMed ID: 36253560
[TBL] [Abstract][Full Text] [Related]
34. The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies.
Albini A; Di Guardo G; Noonan DM; Lombardo M
Intern Emerg Med; 2020 Aug; 15(5):759-766. PubMed ID: 32430651
[TBL] [Abstract][Full Text] [Related]
35. Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
Al-Kuraishy HM; Al-Gareeb AI; Mostafa-Hedeab G; Kasozi KI; Zirintunda G; Aslam A; Allahyani M; Welburn SC; Batiha GE
Front Immunol; 2021; 12():749291. PubMed ID: 34867978
[TBL] [Abstract][Full Text] [Related]
36. Implications of Low-grade Inflammation in SARS-CoV-2 Immunopathology.
Suárez-Reyes A; Villegas-Valverde CA
MEDICC Rev; 2021 Apr; 23(2):42. PubMed ID: 33974614
[TBL] [Abstract][Full Text] [Related]
37. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis.
Saleh J; Peyssonnaux C; Singh KK; Edeas M
Mitochondrion; 2020 Sep; 54():1-7. PubMed ID: 32574708
[TBL] [Abstract][Full Text] [Related]
38. COVID-19 Complications: Oxidative Stress, Inflammation, and Mitochondrial and Endothelial Dysfunction.
Georgieva E; Ananiev J; Yovchev Y; Arabadzhiev G; Abrashev H; Abrasheva D; Atanasov V; Kostandieva R; Mitev M; Petkova-Parlapanska K; Karamalakova Y; Koleva-Korkelia I; Tsoneva V; Nikolova G
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834324
[TBL] [Abstract][Full Text] [Related]
39. SARS-CoV-2 infection and thrombotic complications: a narrative review.
Moschonas IC; Tselepis AD
J Thromb Thrombolysis; 2021 Jul; 52(1):111-123. PubMed ID: 33449290
[TBL] [Abstract][Full Text] [Related]
40. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
Quirch M; Lee J; Rehman S
J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
